Professor of Stroke Medicine
- Chief Executive Officer, Oxford Academic Health Science Network
- Consultant Stroke Physician OUH
My work focuses on developing and evaluating treatments that can reduce brain damage in the first few hours after stroke, and developing better processes of care to deliver for stroke patients.
I have developed and evaluated the performance of stroke recognition instruments such as the Face Arm Speech Test (FAST) and Recognition of Stroke in the Emergency Room Scale (ROSIER) to improve early diagnosis of stroke by the public, ambulance paramedics and Emergency Department teams.
My work has evaluated the risks and benefits of thrombolysis in very elderly stroke patients 80 years or older, who are the population at highest risk of stroke.
In addition to my research in stroke my work more broadly seeks to understand the risks and benefits of drug therapies in older people.
Optimizing lipid management-impact of the COVID 19 pandemic upon cardiovascular risk in England.
Newton JL. et al, (2023), Br Med Bull, 146, 19 - 26
Is bureaucracy being busted in research ethics and governance for health services research in the UK? Experiences and perspectives reported by stakeholders through an online survey.
Snooks H. et al, (2023), BMC Public Health, 23
Research letter: An updated survey of intra-arterial mechanical thrombectomy service provision in England.
White PM. et al, (2023), Eur Stroke J, 8, 598 - 599
Results of an international survey on the status of prehospital care.
Rudd AG. et al, (2023), Int J Stroke
Informed consent in randomised controlled trials: further development and evaluation of the participatory and informed consent (PIC) measure.
Wade J. et al, (2023), Trials, 24